Document is current
Any future updates will be listed below
-
Authors
Elias, Shlomo https://orcid.org/0000-0002-5055-5317
Brown, Samantha https://orcid.org/0000-0001-5352-974X
Egini, Ogechukwu
Walji, Moneeza
Homsy, Sylvester
Velayati, Arash
Devlin, Sean https://orcid.org/0000-0002-6801-720X
Ponce, Doris M. https://orcid.org/0000-0002-9422-5766
Kennedy, Vanessa
Bharadwaj, Sushma
Shiraz, Parveen https://orcid.org/0000-0002-6721-0358
Jakubowski, Ann A.
Papadopoulos, Esperanza B.
Muffly, Lori https://orcid.org/0000-0002-9887-6136
Perales, Miguel-Angel https://orcid.org/0000-0002-5910-4571
Giralt, Sergio A. https://orcid.org/0000-0003-1944-5053
Smith, Melody
Gyurkocza, Boglarka https://orcid.org/0000-0002-2933-2119
- License Information
-
More Information
Article History
Received: 25 July 2025
Revised: 24 October 2025
Accepted: 11 November 2025
First Online: 25 November 2025
Competing interests
: SE received honoraria from Novartis and Gilead. MS reports consultancy for CVS Caremark, advisory for A28 Therapeutics, and patents pertaining to the intestinal microbiome and CAR T cell therapy—US 17/229,184; US 391 63/303,461. M-AP reports honoraria from Adicet, Allogene, Caribou Biosciences, Celgene, Bristol-Myers Squibb, Equilium, Exevir, ImmPACT Bio, Incyte, Kite/Gilead, Merck, Miltenyi Biotec, MorphoSys, Nektar Therapeutics, Novartis, Omeros, OrcaBio, Pierre Fabre, Sanofi, Syncopation, Takeda, VectivBio AG, and Vor Biopharma. He serves on DSMBs for Cidara Therapeutics and Sellas Life Sciences. He has ownership interests in Omeros and OrcaBio. He has received institutional research support for clinical trials from Allogene, Genmab, Incyte, Kite/Gilead, Miltenyi Biotec, Nektar Therapeutics, and Novartis. DMP has served as an advisory board member for Evive Biotechnology (Shanghai) Ltd; has consulted, received honorarium from, or participated in the advisory boards for Sanofi, Ceramedix, and Incyte Corporation, and received research funding from Sanofi and Incyte. All other authors declare no competing financial interests.
: All methods were performed in accordance with the relevant guidelines and regulations. Ethical approval for this retrospective study was obtained from the Institutional Review Boards at MSKCC (16-505 A(22)) and Stanford University (8903). The requirement for informed consent was waived by the ethics committee due to the retrospective nature of the study and the use of de-identified data. No identifiable images of human participants are included in this manuscript.
